Gene 'Signature' and Lung Cancer Cambridge MA

In a finding that could lead to a simple blood test to screen for lung cancer, U.S. researchers have identified immune system markers that indicate early-stage lung tumors in people at high risk for lung cancer.

Therese M Mulvey, MD
(617) 479-3550
10 Willard St
Quincy, MA
Business
Commonwealth Physicians Services Inc
Specialties
Oncology

Data Provided by:
Vincent W Li, MD
(617) 576-5708
PO Box 382111
Cambridge, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Iain J Webb, MD
(617) 551-4975
40 Landsdowne St
Cambridge, MA
Specialties
Internal Medicine, Hematology-Oncology
Gender
Male
Education
Medical School: Mc Gill Univ, Fac Of Med, Montreal, Que,
Graduation Year: 1987

Data Provided by:
Janet L Abrahm, MD
(617) 632-6464
35 West St Apt 5
Cambridge, MA
Specialties
Internal Medicine, Hematology-Oncology
Gender
Male
Education
Medical School: Univ Of Ca, San Francisco, Sch Of Med, S
Graduation Year: 1973

Data Provided by:
Kwok Kin Wong, MD
(617) 726-2000
1 Harvard Pl
Somerville, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Columbia Univ Coll Of Physicians And Surgeons, New York Ny 10032
Graduation Year: 1996

Data Provided by:
Iain James Web, MR
(617) 551-4975
40 Landsdowne St
Cambridge, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Robert Jay Fram, MD
(617) 995-4909
128 Sidney St
Cambridge, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Camille Lucia Bedrosian, MD
(617) 494-0400
26 Landsdowne St
Cambridge, MA
Specialties
Internal Medicine, Medical Oncology
Gender
Female
Education
Medical School: Harvard Med Sch, Boston Ma 02115
Graduation Year: 1983

Data Provided by:
Fabio M Benedetti, MD
(617) 444-1322
40 Landsdowne St
Cambridge, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Elizabeth G Trehu, MD
(617) 444-1281
40 Landsdowne St
Cambridge, MA
Specialties
Oncology (Cancer), Hematology-Internal Medicine
Gender
Female
Education
Medical School: New York Univ Sch Of Med, New York Ny 10016
Graduation Year: 1985
Hospital
Hospital: Jordan Hospital, Plymouth, Ma
Group Practice: Jordan Hospital Club Cncr Ctr

Data Provided by:
Data Provided by:

Gene 'Signature' and Lung Cancer

Provided By:

TUESDAY, Dec. 1 (HealthDay News) -- In a finding that could lead to a simple blood test to screen for lung cancer, U.S. researchers have identified immune system markers that indicate early-stage lung tumors in people at high risk for lung cancer.

The researchers examined gene expression profiles in blood samples from 137 people with non-small cell lung cancer and a control group of 91 people with non-malignant lung diseases, such as chronic obstructive pulmonary disease, emphysema or benign lung nodules.

They identified a 29-gene "signature" that was 86 percent accurate in identifying those with lung cancer, who had certain genetic changes in immune cells that the others did not.

Blood samples were taken from 18 of those with lung cancer before surgery to remove their tumors and two to five months after surgery. After surgery, 13 of them showed a decrease or disappearance of the tumor gene signature.

The study was published online Dec. 1 in Cancer Research.

The researchers said it might be possible to use the findings to develop a simple blood test to screen for lung cancer.

"People routinely get blood taken at their doctors' offices for cholesterol levels, diabetes and other standard tests, so why not utilize this method to screen for other conditions such as the risk of developing lung cancer?" Louise C. Showe, a professor in the molecular and cellular oncology and immunology programs and director of the genomics facility at the Wistar Institute in Philadelphia, said in a news release from the institute.

"Such a test could be especially useful for remote areas where, typically, technologies that are used in urban centers are not available," she said. "In addition, this test could be useful in a clinical setting to help to decide whether a small tumor detected on an X-ray is likely to be malignant."

More information

The U.S. National Cancer Institute has more about lung cancer screening.

SOURCE: Wistar Institute, news release, Dec. 1, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com